These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33726014)

  • 1. Effectiveness of Tong-Xie-Yao-Fang combined with Si-Ni-San for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Jiang J; Chen Y; Hu Z; Li H; Ye J; Yu Z; Tang H
    Medicine (Baltimore); 2021 Mar; 100(11):e25198. PubMed ID: 33726014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis.
    Li YL; Yao CJ; Lei R; Xie F; Xiong Q; Luo LH; Feng PM
    Medicine (Baltimore); 2020 Nov; 99(48):e23457. PubMed ID: 33235133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To assess the effective and safety of compound glutamine entersoluble capsules in irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Zhang Y; Liu R; Wang J; Yan S; Guo Z
    Medicine (Baltimore); 2021 Mar; 100(10):e25098. PubMed ID: 33725903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xiaoyao-san, a traditional Chinese herbal formula, for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.
    Lee J; Sung WS; Kim EJ; Kim YW
    Medicine (Baltimore); 2021 Mar; 100(10):e24019. PubMed ID: 33725813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
    Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
    Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
    BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
    Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
    World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review.
    Bian Z; Wu T; Liu L; Miao J; Wong H; Song L; Sung JJ
    J Altern Complement Med; 2006 May; 12(4):401-7. PubMed ID: 16722791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Shen-Ling-Bai-Zhu-San combined with chemotherapy for lung cancer: A protocol for systematic review and meta-analysis.
    Jiang J; Li Z; Zhang F; Li H; Li R; Qiu Q; Chen B
    Medicine (Baltimore); 2021 Feb; 100(6):e24590. PubMed ID: 33578558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Wang F; He S; Yan J; Mai L; Yang L
    Medicine (Baltimore); 2020 Aug; 99(34):e21817. PubMed ID: 32846822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese medicine for irritable bowel syndrome: A protocol for meta-analysis.
    Yao CJ; Li YL; Pu MJ; Luo LH; Feng PM
    Medicine (Baltimore); 2020 Nov; 99(48):e23394. PubMed ID: 33235116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
    Yin X; Li S; Ouyang M; Ou R; Chen Z; Wei S; Huang H; Liu D
    Ann Palliat Med; 2022 Dec; 11(12):3785-3793. PubMed ID: 36510459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
    Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
    Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis.
    Zhang M; Huang W; Yuan D
    Medicine (Baltimore); 2021 Apr; 100(17):e25747. PubMed ID: 33907170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    He Y; Xu R; Wang W; Zhang J; Hu X
    Medicine (Baltimore); 2020 Aug; 99(32):e21502. PubMed ID: 32769886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.